Long-Term Monitoring and Complications
At a Glance
People with Mal de Meleda need lifelong follow-up for tightening skin, bent fingers or toes, constriction bands that can threaten circulation, and suspicious skin changes. Genetic counseling and emotional support are also important parts of care.
Mal de Meleda is a lifelong condition that requires vigilant monitoring for structural changes to the hands and feet, as well as rare skin complications [1][2]. Consistent follow-up with a specialized care team is the most effective way to preserve function and address issues early [3].
Monitoring Functional Changes
Over decades, the extreme thickening of the skin can exert pressure on the underlying joints and blood vessels. This leads to two primary structural concerns:
- Contractures: The waxy, non-flexible skin and surrounding tissues can pull the fingers or toes into a bent position. These flexion contractures can eventually become persistent, making it difficult to fully open the hands or walk with a normal gait [4][5].
- Pseudoainhum (Constriction Bands): This is a severe complication where a thick band of skin forms a circular constriction around a finger or toe [6]. If left unmanaged, this band can act like a tourniquet. In extremely rare, worst-case scenarios, this can lead to “auto-amputation” (loss of the digit) [7].
Surgical Options: Surgery is individualized and typically reserved for severe disease with tissue loss or functional limitation. Procedures such as a Z-plasty (a surgical technique to lengthen contracted tissue) may be used to release the tension of a constriction band [8]. Skin grafting is occasionally performed, but requires extensive coordination regarding wound care and the risk of recurrence [5][9].
Urgent Care Red Flags: Digit Circulation
A tightening constriction band is a medical emergency if it threatens blood flow. Seek same-day urgent or emergency assessment if a finger or toe becomes:
- Increasingly painful, numb, or tingling.
- Unusually cold to the touch.
- Pale, blue, or black in color.
- Significantly swollen compared to the others.
Note: For red flags regarding infections (such as spreading redness, fever, or pus), please refer to the Daily Skin Care page.
Monitoring for Skin Changes
There is a documented risk of skin cancers—specifically squamous cell carcinoma (SCC) and melanoma—developing within keratoderma sites in patients with Mal de Meleda [10][5]. It is important to understand that this evidence comes from isolated case reports; it does not establish a broadly increased, inevitable cancer risk, nor is there a universal screening schedule for all patients.
However, because the skin is already thickened and scarred, suspicious changes can be hard to spot. You should contact your dermatologist promptly if you notice [10][11]:
- Persistent Ulcers: Any sore or crack that does not heal despite appropriate care.
- Rapidly Changing Lesions: A new lump, bump, or area that grows quickly or becomes firm.
- Spontaneous Bleeding: Areas that bleed or crust without a known injury.
- Pigment Changes: Any new dark spots or changes in color.
The Role of Genetic and Psychosocial Support
Because Mal de Meleda is an inherited condition, genetic counseling is a vital part of long-term care to help you understand inheritance patterns and discuss family planning options [1][12].
Furthermore, chronic pain, visible skin changes, and mobility limitations carry a significant emotional burden [13][14]. Integrating psychosocial support—such as counseling or connecting with rare-disease advocacy groups—into your care plan is just as important as medical treatment for maintaining your overall well-being [13].
Common questions in this guide
What long-term problems can Mal de Meleda cause?
What signs mean a constriction band around a finger or toe needs emergency care?
Which skin changes should I show a dermatologist?
Can Mal de Meleda make it harder to move my hands or walk?
What treatments are available for a severe constriction band?
Why should someone with Mal de Meleda see a genetic counselor?
How can I get support for the emotional impact of Mal de Meleda?
Get notified when new evidence is published on Transgrediens et progrediens palmoplantar keratoderma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Mal de Meleda: A Focused Review.
Perez C, Khachemoune A
American journal of clinical dermatology 2016; (17(1)):63-70 doi:10.1007/s40257-015-0157-1.
PMID: 26445964 - 2
Atypical manifestation of psoriasis in the elderly: possible expression of Mal de Meleda diagnosis review and case report.
Onisor C, Sarpe AM, Niculet E
Frontiers in medicine 2025; (12()):1634843 doi:10.3389/fmed.2025.1634843.
PMID: 41048964 - 3
Japanese guidelines for the management of palmoplantar keratoderma.
Yoneda K, Kubo A, Nomura T, et al.
The Journal of dermatology 2021; (48(8)):e353-e367 doi:10.1111/1346-8138.15850.
PMID: 34121213 - 4
A Mal De Meleda patient with severe flexion contractures of hands and feet: A case report in West China.
Pan Y, Zhao H, Chen A, Huang X
Medicine 2017; (96(36)):e7972 doi:10.1097/MD.0000000000007972.
PMID: 28885351 - 5
[Acral melanoma in a patient with hereditary keratoderma of the palms and soles (mal de Meleda): A chance association?]
Korbi M, Hickman G, Routier E, et al.
Annales de dermatologie et de venereologie 2019; (146(11)):730-736 doi:10.1016/j.annder.2019.08.013.
PMID: 31582262 - 6
A novel homozygous mutation disrupting the initiation codon in the SLURP1 gene underlies mal de Meleda in a consanguineous family.
Shah K, Nasir A, Irfanullah , et al.
Clinical and experimental dermatology 2016; (41(6)):675-679 doi:10.1111/ced.12864.
PMID: 29226984 - 7
Palmoplantar keratoderma, pseudo-ainhum and knuckle pads in an African patient: A case report.
Govender KC, Pillay S
SAGE open medical case reports 2023; (11()):2050313X231204197 doi:10.1177/2050313X231204197.
PMID: 37846342 - 8
[Ainhum and "African acral keratoderma": three cases].
Koudoukpo C, Bourrat E, Rausky J, et al.
Annales de dermatologie et de venereologie 2015; (142(3)):170-5.
PMID: 25624138 - 9
Treatment of a chronic skin lesion in the lower limb in Meleda disease.
Nebbioso G, Nebbioso V, Petrella F
Journal of wound care 2022; (31(3)):224-228 doi:10.12968/jowc.2022.31.3.224.
PMID: 35199600 - 10
SLURP-1 is mutated in Mal de Meleda, a potential molecular signature for melanoma and a putative squamous lineage tumor suppressor gene.
Bergqvist C, Kadara H, Hamie L, et al.
International journal of dermatology 2018; (57(2)):162-170 doi:10.1111/ijd.13850.
PMID: 29231248 - 11
A Rare Syndrome Resembling Scleroderma: Huriez Syndrome.
Çelik NS, Yaşar Ş, Aytekin S, Güneş P
Skin appendage disorders 2018; (4(2)):82-85 doi:10.1159/000479036.
PMID: 29765964 - 12
Identification of novel homozygous SLURP1 mutation in a Javanese family with Mal de Meleda.
Radiono S, Pramono ZAD, Oh GGK, et al.
International journal of dermatology 2017; (56(11)):1161-1168 doi:10.1111/ijd.13776.
PMID: 29023701 - 13
Mal de Meleda: A great imitator.
Bakija-Konsuo A, Zitinski M, Fatovic-Ferencic S
Clinics in dermatology 2019; (37(3)):175-181 doi:10.1016/j.clindermatol.2019.01.003.
PMID: 31178100 - 14
Investigation of Nagashima-type palmoplantar keratoderma in China: A cross-sectional study of 234 patients.
Liu J, Chen Z, Hu L, et al.
The Journal of dermatology 2023; (50(3)):375-382 doi:10.1111/1346-8138.16621.
PMID: 36317385
This page is for informational purposes only and does not constitute medical advice. Your dermatologist and specialized care team should guide monitoring, urgent assessment, surgery, and family-planning decisions for Mal de Meleda.